Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the drug-drug interactions between BI 201335 and BI 207127 as well as their
combined effect on CYP probe drug substrates and on tenofovir and raltegravir in treatment
naive or prior treatment relapse patients with chronic hepatitis C infection.